1
|
Nikova A, Ganchev D, Birbilis T. Possible Considerations for the Management of Turcot’s Syndrome? CURRENT CANCER THERAPY REVIEWS 2019. [DOI: 10.2174/1573394714666180731094420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
Turcot’s syndrome (TS) is a rare disease with known incidence of about
1-2 cases per year. It is, however, linked to high mortality due to the brain cancer. And because of
this, we propose recommendations, aimed at preventing the mortality of the patients and to minimize
the risk of undiagnosed Turcot’s syndrome.
Methods:
The authors collected the worldwide published data on TS, from the year of its definition
till 2018, all of which was published on the search engines, such as Medline, Medknow, Cohraine
and Wiley.
Results:
We included 97 patients, 57 from which are females and 40 males with median age of 22
years. The most common type of cancer is medulloblastoma, followed by glioblastoma and astrocytoma.
We further divided the patients into two categories based on the first symptom of the disease
and we made an algorithm of approaching these patients.
Conclusion:
TS is a disease that affects mostly members of families with multiple genetic mutations
and types of cancers. And because of the unknown mechanisms of inheritance, it is useful to
establish guidelines for the approach of those patients, in order to minimize the high mortality
rate.
Collapse
Affiliation(s)
- Alexandrina Nikova
- Department of Neurosurgery, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
| | - Dimitar Ganchev
- Department of Radiation Oncology, University Hospital Queen Giovanna, Sofia, Bulgaria
| | - Theodossios Birbilis
- Department of Neurosurgery, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
| |
Collapse
|
2
|
Ninclaus VGS, Walraedt S, Baert E, Laureys G, Leroy BP, De Zaeytijd J. Diplopia as presenting sign of Turcot syndrome. Int Ophthalmol 2016; 37:275-278. [PMID: 27143045 DOI: 10.1007/s10792-016-0246-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2016] [Accepted: 04/25/2016] [Indexed: 11/26/2022]
Abstract
PURPOSE To describe a patient with diplopia who was diagnosed with Turcot syndrome. METHODS A 10-year-old boy presented with a history of left-sided sixth and seventh nerve palsy. He underwent imaging of the brain and colon, a full ophthalmological and genetic work-up. RESULTS A 10-year-old boy was referred with combined left-sided sixth and seventh nerve palsy since 1 month without symptoms of raised intracranial pressure. BCVA was 6/6 in both eyes. Fundoscopy revealed bilateral, multiple, oval pigmented ocular fundus lesions (POFLs) in the 4 quadrants. These POFLs, together with the cranial nerve palsies raised the suspicion of Turcot syndrome, a familial neoplasia syndrome characterized by familial colorectal cancer and tumours of the central nervous system. Urgent MRI scan of the brain and stereotactic biopsy showed a primitive neuroectodermal tumour (PNET) at the pons. Coloscopy revealed multiple polyps. DNA analysis of the APC gene confirmed the clinical diagnosis of Turcot syndrome. The PNET was treated with combined radio- and chemotherapy. The patient underwent a prophylactic total colectomy as virtually all patients develop a carcinoma of the colorectal region if left untreated. CONCLUSIONS Although strabismus is not, diplopia in childhood is rare and seldom innocuous. It requires a prompt and thorough diagnostic evaluation, including thorough, dilated fundoscopy. The presence of POFLs combined with neurological symptoms suggestive of a brain tumour should alert the clinician of the possibility of Turcot syndrome. Recognition of this rare syndrome can lead to earlier diagnosis, which is vital for appropriate surveillance and early surgical intervention of the highly frequent neoplasias in Turcot Syndrome.
Collapse
Affiliation(s)
- Virginie G S Ninclaus
- Department of Ophthalmology, Ghent University Hospital & Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
| | - Sophie Walraedt
- Department of Ophthalmology, Ghent University Hospital & Ghent University, De Pintelaan 185, 9000, Ghent, Belgium
| | - Edward Baert
- Department of Neurosurgery, Ghent University Hospital & Ghent University, Ghent, Belgium
| | - Geneviève Laureys
- Department of Pediatric Hematology and Oncology, Ghent University Hospital & Ghent University, Ghent, Belgium
| | - Bart P Leroy
- Department of Ophthalmology, Ghent University Hospital & Ghent University, De Pintelaan 185, 9000, Ghent, Belgium
- Center for Medical Genetics, Ghent University Hospital & Ghent University, Ghent, Belgium
- Division of Ophthalmology & Center for Cellular & Molecular Therapeutics, The Childrens' Hospital of Philadelphia, Philadelphia, PA, USA
| | - Julie De Zaeytijd
- Department of Ophthalmology, Ghent University Hospital & Ghent University, De Pintelaan 185, 9000, Ghent, Belgium
| |
Collapse
|
3
|
First case report of turcot syndrome type 1 in Colombia. Case Rep Oncol Med 2012; 2012:356384. [PMID: 23320220 PMCID: PMC3535726 DOI: 10.1155/2012/356384] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2012] [Accepted: 11/26/2012] [Indexed: 12/01/2022] Open
Abstract
Turcot syndrome is an autosomal recessive disorder
clinically characterized by the occurrence of primary tumors of the central
nervous system and adenomatous colonic polyps during the first or second
decades of life, with a spectrum of clinical features such as “café-au-lait”
spots, axillary freckling, and hyperpigmented spots. Currently its prevalence globally and
in Colombia remains unknown. We present the case of a 20-year-old male with a clinical
presentation of both glioblastoma multiforme and multiple adenomatous colonic polyps.
The molecular genetics study revealed a mutation in KrasAsp12 gene and altered expression of HMSH2 and HMSH6 proteins encoded by the DNA mismatch repair genes in two of the colonic polyps. Even though this clinical presentation may suggest a shorter survival rate, this patient is still alive after seven months of treatment. A literature review complements this report.
Collapse
|
4
|
Ma S, Hu Y, Yang J, Zhou X. Turcot's syndrome associated with intestinal non-Hodgkin's lymphoma: case report and review of literature. Clin Neurol Neurosurg 2012; 115:117-20. [PMID: 22676959 DOI: 10.1016/j.clineuro.2012.04.026] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2012] [Revised: 04/12/2012] [Accepted: 04/30/2012] [Indexed: 11/30/2022]
Abstract
A 15-year-old boy was admitted with the diagnosis of colonic polyposis, and during a 2-year follow-up, he underwent operation for right parieto-occipital anaplastic astrocytoma, left-side colonic non-Hodgkin lymphoma (NHL) and cerebella glioblastoma which were all confirmed by histology. Although cases of Turcot's syndrome (TS) (colonic polyposis and primary brain tumour occurring in the same patient) have been previously described, association with haematological malignancy is rare. We hereby report such a case with TS.
Collapse
Affiliation(s)
- ShunChang Ma
- Neurosurgery, Fuxing Hospital Affiliated to Capital Medical University, Beijing, China.
| | | | | | | |
Collapse
|
5
|
Turcot syndrome: a case report in an unsuspected setting. J Gastrointest Surg 2012; 16:411-4. [PMID: 21959784 DOI: 10.1007/s11605-011-1698-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2011] [Accepted: 09/14/2011] [Indexed: 01/31/2023]
|
6
|
Affiliation(s)
- Joanna L Weinstein
- Division of Hematology, Oncology and Stem Cell Transplantation, Children's Memorial Hospital, Chicago, IL, USA.
| | | | | |
Collapse
|
7
|
Affiliation(s)
- Takeshi MINAMI
- *Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
| | - Yasuhisa SHINOMURA
- *Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
| | - Seiichiro TARUI
- *Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
| | - Takuji MONDEN
- **Second Department of Surgery, Osaka University Medical School, Osaka, Japan
| | - Takashi SHIMANO
- **Second Department of Surgery, Osaka University Medical School, Osaka, Japan
| | - Norio YONEDA
- ***Department of Neurosurgery, Osaka University Medical School, Osaka, Japan
| | - Masami SAKURAI
- ****Department of Pathology, Osaka University Hospital, Osaka, Japan
| |
Collapse
|
8
|
Lebrun C, Olschwang S, Jeannin S, Vandenbos F, Sobol H, Frenay M. Turcot syndrome confirmed with molecular analysis. Eur J Neurol 2007; 14:470-2. [PMID: 17389002 DOI: 10.1111/j.1468-1331.2006.01669.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Turcot syndrome is clinically characterized by the occurrence of primary brain tumor and colorectal tumor and has, in previous reports, been shown associated with germline mutations in the genes APC, MLH1, MHS6, and PMS2. To date, only few families have been documented by molecular analysis. We report two new families with Turcot syndrome to illustrate and review its characteristics and facilitate diagnosis. Molecular analysis revealed two germline mutations, one in the MLH1 gene and one in MSH2. The latter has never been describe in the literature. Personal and familial relevant anamnestic data from patients with glioma might aid in the diagnosis of genetic disorders. The subsequent molecular characterization may contribute to the appropriate care of affected patients and asymptomatic gene carriers.
Collapse
Affiliation(s)
- C Lebrun
- Service de Neurologie, Hôpital Pasteur, Nice, France.
| | | | | | | | | | | |
Collapse
|
9
|
Hegde MR, Chong B, Blazo ME, Chin LHE, Ward PA, Chintagumpala MM, Kim JY, Plon SE, Richards CS. A homozygous mutation in MSH6 causes Turcot syndrome. Clin Cancer Res 2005; 11:4689-93. [PMID: 16000562 DOI: 10.1158/1078-0432.ccr-04-2025] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Heterozygous mutations in one of the DNA mismatch repair genes cause hereditary nonpolyposis colorectal cancer (MIM114500). Turcot syndrome (MIM276300) has been described as the association of central nervous system malignant tumors and familial colorectal cancer and has been reported to be both a dominant and recessive disorder. Homozygous and compound heterozygous mutations in APC, MLH1, MSH2, and PMS2 genes have been reported in five families. Here we describe a nonconsanguineous Pakistani family, including a son with lymphoma and colorectal cancer diagnosed at ages 5 and 8, respectively, and an 8-year-old daughter with glioblastoma multiforme. Both children had features of neurofibromatosis type 1 including atypical café au lait spots and axillary freckling without a family history consistent with neurofibromatosis type 1, familial adenomatous polyposis, or hereditary nonpolyposis colorectal cancer. Mutational analysis was done for MLH1, MSH2, and MSH6 using denaturing high-performance liquid chromatography and sequencing of a blood sample from the daughter. A novel homozygous single base insertion mutation was identified (3634insT) resulting in a premature stop at codon 1,223 in exon 7 of the MSH6 gene. Both parents were found to be heterozygous for the 3634insT mutation. Microsatellite instability testing showed instability in the glioblastoma sample. We report here the first identification of a homozygous mutation in MSH6 in a family with childhood-onset brain tumor, lymphoma, colorectal cancer, and neurofibromatosis type 1 phenotype. Our findings support a role for MSH6 in Turcot syndrome and are consistent with an autosomal recessive mode of inheritance.
Collapse
Affiliation(s)
- Madhuri R Hegde
- Diagnostic Sequencing Laboratory, Department of Molecular and Human Genetics and Texas Children's Cancer Center, Houston, Texas 77030, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Agostini M, Tibiletti MG, Lucci-Cordisco E, Chiaravalli A, Morreau H, Furlan D, Boccuto L, Pucciarelli S, Capella C, Boiocchi M, Viel A. Two PMS2 mutations in a Turcot syndrome family with small bowel cancers. Am J Gastroenterol 2005; 100:1886-91. [PMID: 16144131 DOI: 10.1111/j.1572-0241.2005.50441.x] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
We report the clinicopathological, genetic, and immunohistochemical characterization of an atypical Turcot syndrome (TS) family with small bowel cancer. The tumor family history of a patient with cafè-au-lait spots (CALS) and early onset adenomas, duodenal cancer, and glioblastoma was positive for colonic adenoma (mother), jejunal (maternal grandfather), lung (father), and colorectal (paternal uncle) cancers. PMS2 genetic testing identified the nonsense 1951C>T (Q643X) and the missense 161C>T (S46I) mutations. PMS2 expression was absent in the proband's duodenal cancer with high microsatellite instability. The normal cells also displayed no PMS2 expression and some degree of instability. Our findings point out the association between PMS2 and TS, and support the hypothesis that patients with a few polyps, small bowel tumors with a very early onset, glioblastoma, and CALS should be considered as a variant of hereditary nonpolyposis colorectal cancer. A recessive model of inheritance caused by compound heterozygous mutations was consistent with the observed severe clinical phenotype and has important implications for predicting cancer risk in both the proband and his relatives.
Collapse
Affiliation(s)
- Marco Agostini
- Department of Preclinical Research and Epidemiology, Experimental Oncology 1, Centro Riferimento Oncologico, IRCCS, Aviano, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Murphy HR, Taylor W, Ellis A, Sturgess R. An unusual case of Turcot’s syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin’s lymphoma, and duodenal adenocarcinoma. Review of the classification and genetic basis of Turcot’s syndrome. Fam Cancer 2005; 4:139-43. [PMID: 15951965 DOI: 10.1007/s10689-004-2759-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2004] [Accepted: 08/29/2004] [Indexed: 11/28/2022]
Abstract
A 38-year-old man with a history of colonic and small bowel polyposis and glioblastoma was investigated for dyspepsia. Upper GI endoscopy identified an abnormal area in the duodenum, confirmed by histology as high grade non-Hodgkin's B cell MALT lymphoma. Although cases of Turcot's syndrome (TS) (colonic polyposis and primary brain tumour occurring in the same patient) have been previously described, association with haematological malignancy is rare. This is the first report of intestinal lymphoma occurring in an adult with TS.
Collapse
Affiliation(s)
- H R Murphy
- Department of Clinical Genetics, Royal Liverpool Children's Hospital-Alder Hey, Eaton Road, Liverpool, L12 2AP, UK.
| | | | | | | |
Collapse
|
12
|
Other Polyposis of the Large Bowel. COLORECTAL CANCER 2002. [DOI: 10.1007/978-3-642-56008-8_12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Shibata C, Sasaki I, Naito H, Funayama Y, Fukushima K, Masuko T, Takahashi K, Ogawa H, Sato S, Ueno T, Hashimoto A, Matsuno S, Kinouchi Y, Hiwatashi N. Turcot syndrome with colonic obstruction and small intestinal invagination: report of a case. Surg Today 1999; 29:785-8. [PMID: 10483758 DOI: 10.1007/bf02482328] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
We report herein the case of a 16-year-old boy diagnosed as having Turcot syndrome, otherwise known as glioma-polyposis syndrome. The patient was transferred from the Department of Neurosurgery where he was undergoing investigation of a brain tumor, to the Department of Medicine for investigation of gastrointestinal symptoms. The patient was diagnosed as having Turcot syndrome, and was then transferred to the Department of Surgery for treatment of an obstruction in the sigmoid colon and small intestinal invagination. A subtotal colectomy with side-to-end ileoproctostomy and release of the invaginations was carried out. Multiple polyps were found in the colon, two of which, including a large polyp that obstructed the colonic lumen, were confirmed histologically to be adenocarcinoma. The remaining polyps were adenomas. A biopsy of the brain tumor confirmed a diagnosis of astrocytoma (WHO grade II). This case report describes the characteristic features of Turcot syndrome presented by this patient.
Collapse
Affiliation(s)
- C Shibata
- First Department of Surgery, Tohoku University School of Medicine, Sendai, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Taylor MD, Perry J, Zlatescu MC, Stemmer-Rachamimov AO, Ang LC, Ino Y, Schwartz M, Becker LE, Louis DN, Cairncross JG. The hPMS2 exon 5 mutation and malignant glioma. Case report. J Neurosurg 1999; 90:946-50. [PMID: 10223463 DOI: 10.3171/jns.1999.90.5.0946] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Patients with Turcot syndrome (TS) are predisposed to colon tumors and primary brain tumors, typically glioblastomas or medulloblastomas. The authors describe a patient with TS featuring a known germline mutation of exon 5 of the hPMS2 mismatch repair gene who developed two metachronous glioblastomas, both with distinct oligodendroglial features. Molecular genetic analysis revealed allelic loss of chromosome 19q in the patient's second tumor but no allelic loss of chromosome 1p. Prominent microsatellite instability was also found in this tumor, consistent with a germline mismatch repair defect. Because this patient had an unusual underlying condition and his tumor had a unique histological appearance for TS, it was hypothesized that this genetic defect may predispose to malignant gliomas with oligodendroglial features. The authors therefore evaluated whether sporadic glioblastomas and oligodendrogliomas undergo mutations of this region of the hPMS2 gene. However, single-strand conformation polymorphism analysis of hPMS2 exon 5 failed to reveal mutations in 20 sporadic glioblastomas and 16 sporadic oligodendroglial gliomas. Thus, although it is possible that the germline hPMS2 exon 5 mutation may predispose to glioblastomas with an oligodendroglial component, the same genetic defect is not commonly involved in sporadic oligodendrogliomas or glioblastomas.
Collapse
Affiliation(s)
- M D Taylor
- Department of Medicine, University of Toronto, Ontario, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Matsui T, Hayashi N, Yao K, Yao T, Takenaka K, Hoashi T, Takemura S, Iwashita A, Tanaka A, Koga M. A father and son with Turcot's syndrome: evidence for autosomal dominant inheritance: report of two cases. Dis Colon Rectum 1998; 41:797-801. [PMID: 9645753 DOI: 10.1007/bf02236273] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Typical Turcot's syndrome is characterized by the association of a brain glioma together with multiple colonic polyposis, in which the number of polypoid lesions is small and the association of colonic cancer occurs at a younger age than in familial adenomatous polyposis. We describe a family in which both the father and his son presented with typical Turcot's syndrome without parental consanguinity. This is the first report of a family that is considered to follow an autosomal dominant inheritance. After reviewing 25 documented cases in which the average age of death was 20.3 years old, it was learned that the major cause of death was brain tumor (76 percent) and the minor cause was colon cancer (16 percent). Patients were very young and, therefore, unlikely to have produced a child before their death. These facts seem to support the theory that Turcot's syndrome is an autosomal dominant disorder.
Collapse
Affiliation(s)
- T Matsui
- Department of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Mullins KJ, Rubio A, Myers SP, Korones DN, Pilcher WH. Malignant ependymomas in a patient with Turcot's syndrome: case report and management guidelines. SURGICAL NEUROLOGY 1998; 49:290-4. [PMID: 9508117 DOI: 10.1016/s0090-3019(97)00299-1] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND Turcot's Syndrome is the association of multiple adenomatous polyps of the colon with a primary tumor of the central nervous system. We present the first reported case of Turcot's Syndrome in a patient with malignant ependymomas. Recent advances in the elucidation of the genetic basis for the hereditary forms of colon cancer have provided a clearer understanding of the etiology of Turcot's Syndrome. This new information is relevant to the neurosurgical community and provides updated guidelines in the diagnosis and management of patients with this complex disease process. RESULTS Turcot's Syndrome is related to two distinct genetic errors. The first involves a germ-line mutation in the adenomatous polyposis coli (APC) gene, which is postulated to act as a tumor suppressor gene. The second is a germ-line defect in one of a group of genes responsible for DNA nucleotide mismatch repair. CONCLUSION The elucidation of the gene defects responsible for the hereditary forms of colon cancer has provided a clearer understanding of the molecular basis of Turcot's Syndrome. Patients with hereditary forms of colon cancer and neurologic symptoms require immediate and thorough investigation because of their significantly increased risk of developing CNS tumors. Previously healthy patients diagnosed with a CNS tumor with a family history of adenomatous polyposis coli should undergo screening and surveillance colonoscopy as the CNS lesion may precede colonic symptoms. CNS screening guidelines for asymptomatic patients with adenomatous polyposis coli requires further risk analysis studies. All patients diagnosed with Turcot's Syndrome should be tested for the gene defect, including the CNS tumor tissue to provide further data on the genetic relationship between Turcot's Syndrome and the hereditary forms of colon cancer.
Collapse
Affiliation(s)
- K J Mullins
- Division of Neurological Surgery, Strong Memorial Hospital, University of Rochester School of Medicine, New York 14642-8670, USA
| | | | | | | | | |
Collapse
|
17
|
Suzui M, Yoshimi N, Hara A, Morishita Y, Tanaka T, Mori H. Genetic alterations in a patient with Turcot's syndrome. Pathol Int 1998; 48:126-33. [PMID: 9589476 DOI: 10.1111/j.1440-1827.1998.tb03881.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Turcot's syndrome (TS) is a rare disorder associated with the development of both brain and colon neoplasms. Because of the very low incidence of the disease, its molecular basis remains unclear. Presented is a TS case of a 30-year-old Japanese male with a histopathologically confirmed diagnosis of both brain tumor (glioblastoma multiforme) and colon tumor (well-differentiated adenocarcinoma). Germline mutations of the p53 gene, somatic mutations of the Ki-ras, p53 and APC genes, and microsatellite instability (MSI) was examined using polymerase chain reaction (PCR)-single strand conformation polymorphism analysis, followed by PCR-direct sequencing, and sequencing after subcloning. No germline mutations of the p53 gene were found. Somatic mutations of Ki-ras and APC genes were found in the colon adenocarcinoma but not in the brain tumor. No somatic mutation of the p53 gene was present in either colon or brain tumors. Microsatellite instability of both colon and brain tumors was positive in two of four loci. These results indicate that the colon tumor of the TS patient carries the Ki-ras and APC gene mutations. The finding of MSI in both the brain and the colon tumors may support the hypothesis that alterations of DNA repair genes are involved in the tumor development of the TS patient.
Collapse
Affiliation(s)
- M Suzui
- First Department of Pathology, Gifu University School of Medicine, Japan
| | | | | | | | | | | |
Collapse
|
18
|
Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B. The molecular basis of Turcot's syndrome. N Engl J Med 1995; 332:839-47. [PMID: 7661930 DOI: 10.1056/nejm199503303321302] [Citation(s) in RCA: 810] [Impact Index Per Article: 27.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
BACKGROUND Turcot's syndrome is characterized clinically by the concurrence of a primary brain tumor and multiple colorectal adenomas. We attempted to define the syndrome at the molecular level. METHODS Fourteen families with Turcot's syndrome identified in two registries and the family originally described by Turcot and colleagues were studied. Germ-line mutations in the adenomatous polyposis coli (APC) gene characteristic of familial adenomatous polyposis were evaluated, as well as DNA replication errors and germline mutations in nucleotide mismatch-repair genes characteristic of hereditary nonpolyposis colorectal cancer. In addition, a formal risk analysis for brain tumors in familial adenomatous polyposis was performed with a registry data base. RESULTS Genetic abnormalities were identified in 13 of the 14 registry families. Germ-line APC mutations were detected in 10. The predominant brain tumor in these 10 families was medulloblastoma (11 of 14 patients, or 79 percent), and the relative risk of cerebellar medulloblastoma in patients with familial adenomatous polyposis was 92 times that in the general population (95 percent confidence interval, 29 to 269; P < 0.001). In contrast, the type of brain tumor in the other four families was glioblastoma multiforme. The glioblastomas and colorectal tumors in three of these families and in the original family studied by Turcot had replication errors characteristic of hereditary nonpolyposis colorectal cancer. In addition, germ-line mutations in the mismatch-repair genes hMLH1 or hPMS2 were found in two families. CONCLUSIONS The association between brain tumors and multiple colorectal adenomas can result from two distinct types of germ-line defects: mutation of the APC gene or mutation of a mismatch-repair gene. Molecular diagnosis may contribute to the appropriate care of affected patients.
Collapse
Affiliation(s)
- S R Hamilton
- Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205-2196
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Abstract
In this review we provide evidence for the existence of genes associated with primary malignant brain tumors. We summarize the current knowledge from studies of familial cancer aggregation, hereditary syndromes, and molecular and cytogenetic studies. The epidemiologic evidence is suggestive but inconclusive for an association between brain tumors and cancers in other family members, including cancers of the breast, lung and colon. Central nervous system (CNS) tumors have been associated with several hereditary syndromes including the Li-Fraumeni cancer family syndrome, neurofibromatosis (types 1 and 2), tuberous sclerosis, nevoid basal cell carcinoma syndrome, familial polyposis, and von Hippel-Lindau disease. Significant studies leading to the recognition of molecular and cytogenetic abnormalities in malignant gliomas are described in detail. The genetic studies conducted thus far suggest a role for inherited susceptibility in some CNS tumors.
Collapse
Affiliation(s)
- M Bondy
- Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston
| | | | | | | |
Collapse
|
20
|
Itoh H, Hirata K, Ohsato K. Turcot's syndrome and familial adenomatous polyposis associated with brain tumor: review of related literature. Int J Colorectal Dis 1993; 8:87-94. [PMID: 8409693 DOI: 10.1007/bf00299334] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
We investigated clinical manifestations in 124 patients with a possible Turcot's syndrome whose data were taken from documented cases. The cases were subclassified mainly on the bases of the type of familial occurrence and listed in five Tables. We searched for differences in colonic manifestation, histologic type of glioma, mode of inheritance, frequency of parental consanguinity, skin lesions and other accompanying lesions among these five groups. The differences of these clinical findings suggested that glioma-polyposis syndrome should be classified as follows; (1) cases of Turcot's syndrome who had characteristic colonic and brain manifestations, (2) cases of FAP associated with glioma, (3) suspicious cases of glioma-polyposis, and (4) cases other than glioma-polyposis syndrome.
Collapse
Affiliation(s)
- H Itoh
- Department of Surgery I, University of Occupational and Environmental Health, Kitakyushu, Japan
| | | | | |
Collapse
|
21
|
Tops CM, Vasen HF, van Berge Henegouwen G, Simoons PP, van de Klift HM, van Leeuwen SJ, Breukel C, Fodde R, den Hartog Jager FC, Nagengast FM. Genetic evidence that Turcot syndrome is not allelic to familial adenomatous polyposis. AMERICAN JOURNAL OF MEDICAL GENETICS 1992; 43:888-93. [PMID: 1322639 DOI: 10.1002/ajmg.1320430528] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Turcot syndrome (TS) is a rare genetic disease in which brain tumors occur in association with colonic polyposis. Since Turcot's original description in 1959, there have been disagreements about the mode of inheritance as well as the clinical expression of this condition. Some investigators maintain that TS is a phenotypic variant of the autosomal dominant familial adenomatous polyposis (FAP), while others observe that there are clinical differences between TS and FAP, and that the pattern of inheritance of TS is autosomal recessive. The distribution of persons with colonic lesions in a family with a patient of colonic polyposis and a brain tumor, described in this report, favored the recessive hypothesis. In this family, the involvement of the FAP gene on chromosome 5q21-q22 could be excluded by a linkage study using a panel of FAP-linked DNA markers. This finding, which indicates the occurrence of another polyposis gene elsewhere in the genome, will have consequences for the presymptomatic diagnosis of FAP by linked DNA markers. We conclude that TS is a distinct clinical-genetical entity with the triad of atypical polyposis coli, CNS tumors, and a recessive mode of inheritance.
Collapse
Affiliation(s)
- C M Tops
- MCG-Human Genetics Department, University of Leiden, The Netherlands
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Abstract
A non-familial case of cerebellar medulloblastoma associated with adenomatous polyposis coli is described and the literature is reviewed. This is the second reported case of Turcot's syndrome in Australia. A greater understanding of the genetic implications of this rare condition might be achieved through reporting of cases and long-term documentation with polyposis registries.
Collapse
Affiliation(s)
- P F Anseline
- Colorectal Unit, John Hunter Hospital, New South Wales, Australia
| |
Collapse
|
23
|
Bondy ML, Lustbader ED, Buffler PA, Schull WJ, Hardy RJ, Strong LC. Genetic epidemiology of childhood brain tumors. Genet Epidemiol 1991; 8:253-67. [PMID: 1756948 DOI: 10.1002/gepi.1370080406] [Citation(s) in RCA: 54] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The study goal was to determine the genetic (heritable) contribution to childhood brain tumors (CBT) which cause nearly one quarter of all childhood cancer deaths. Their etiology remains unknown, but previous studies have suggested a proportion of CBT may be heritable. In this study we collected family histories of 243 confirmed CBT patients referred to The University of Texas M. D. Anderson Cancer Center between the years 1944 and 1983, diagnosed before age 15, and residents of the United States or Canada. Family histories were obtained for all the probands' first degree relatives (parents, siblings, and offspring) and extended to include selected second degree relatives (aunts, uncles, grandparents) using sequential sampling. To determine if these CBT families exhibited excess cancer, we compared their cancer experience to age-, race-, sex-, and calendar-year specific rates from the Connecticut Tumor Registry. No cancer excess was observed among 1,099 first and second degree relatives [39 cancers observed (O) and 44 expected (E) for a standardized incidence ratio (SIR) of 0.88]. For colon cancer, although small numbers, five cases were observed among the probands' first degree relatives with 1.6 expected, for a significant SIR of 3.10. Segregation analysis demonstrated that chance alone could not account for the observed cancer distribution with a multifactorial model providing the best overall explanation of the data. Overall, heredity played a role in the etiology of CBT in 4% of the study families: four (1.7%) due to known hereditary syndromes (nevoid basal cell carcinoma syndrome and von Recklinghausens neurofibromatosis--NF-1), four (1.7%) with multifactorial inheritance, and two additional families with cancers aggregating similar to the clinical criteria described for the Li-Fraumeni cancer family syndrome.
Collapse
Affiliation(s)
- M L Bondy
- Division of Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston
| | | | | | | | | | | |
Collapse
|
24
|
Sussman A, Leviton A, Allred EN, Aschenbrener C, Austin DF, Gilles FH, Hedley-Whyte ET, Kolonel LN, Lyon JL, Swanson GM. Childhood brain tumor: presentation at younger age is associated with a family tumor history. Cancer Causes Control 1990; 1:75-9. [PMID: 2102279 DOI: 10.1007/bf00053186] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
In a registry-based sample of 361 children with a brain tumor, those whose grandparents and great-grandparents had a history of any kind of tumor were younger at the time of presentation than were those who lacked this family history (p = 0.1). In post hoc analyses, the age difference was most apparent among children with cerebral tumors, and when family history was limited to brain tumors and to great-grandparents. These findings are in keeping with the hypothesis that a familial tumor diathesis contributes to an early age at onset of a brain tumor in some children.
Collapse
|
25
|
Vellutini EA, Pahl FH, Vieira MJ, De Aguiar PH, Vellutini DF, De Almeida GM, Habr-Gama A. [Turcot syndrome: a report of 2 cases]. ARQUIVOS DE NEURO-PSIQUIATRIA 1990; 48:102-6. [PMID: 2165772 DOI: 10.1590/s0004-282x1990000100015] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The authors describe two patients with the association of polyposis-coli and central nervous system tumor (Turcot's syndrome). Clinical, genetic and therapeutic aspects are discussed.
Collapse
Affiliation(s)
- E A Vellutini
- Serviço de Neurocirurgia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Brasil
| | | | | | | | | | | | | |
Collapse
|
26
|
Genetic Predisposition to Colorectal Cancer. COLORECTAL CANCER 1989. [DOI: 10.1007/978-3-642-85930-4_2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
27
|
Abstract
Turcot's syndrome represents the association between familial multiple polyposis coli and neural tumors. The syndrome is reviewed with reference to genetics, colonic and central nervous system manifestations. This evidence suggests that Turcot's syndrome represents one manifestation of the pleiotropic autosomal dominant gene responsible for familial polyposis coli and the associated extracolonic manifestations of Gardner's syndrome. A diagnosis of Turcot's syndrome should be restricted to those patients with familial polyposis coli associated with gliomas or medulloblastomas. A further case is presented that is believed to be the first report of such a case in the United Kingdom.
Collapse
Affiliation(s)
- L Jarvis
- Department of Radiodiagnosis, Freedom Fields Hospital, Plymouth, Devon, United Kingdom
| | | | | | | |
Collapse
|